Multiple sclerosis treatment market to reach $33.02 billion by 2030 at 4.7% cagr, driven by growing prevalence of neurological disorders and rising demand for long-term disease management solutions.
Read More
Multiple sclerosis drugs market to reach $61.43 billion by 2030 at 13.0% cagr, driven by strong support from government and non-government organizations funding research and treatment programs.
Read More
Multiple myeloma drugs market to reach $31.61 billion by 2030 at 6.7% cagr, driven by increasing prevalence of hematological cancer and growing demand for effective targeted therapies.
Read More
Multidrug resistant bacteria market to reach $18.77 billion by 2030 at 7.4% cagr, driven by increasing prevalence of infectious diseases.
Read More
Mucolipidosis ii market to reach $16.19 billion by 2030 at 3.5% CAGR, driven by rise in gene therapy, increased research and development activities, and growing number of clinical trials.
Read More
Mtor inhibitors market to reach $10.39 billion by 2030 at 6.2% CAGR, driven by rise in prevalence of kidney diseases.
Read More
The global Msi-h and dmmr market to reach $21.13 billion by 2030 at 22.7% CAGR, driven by rising prevalence of cancer.
Read More
mRNA Therapeutics CDMO Market Anticipated to Record Steady Gains, Advancing to $8.26 Billion by 2030
Mrna therapeutics cdmo market to reach $8.26 billion by 2030 at 11.7% CAGR, driven by growing burden of chronic and infectious diseases.
Read More
Mrna therapeutics market to reach $42.32 billion by 2030 at 3.3% CAGR, driven by increasing prevalence of long-lasting and communicable diseases.
Read More
Mrna cancer vaccines and therapeutics market to reach $141.51 billion by 2030 at 14.4% CAGR, driven by rising prevalence of cancer.
Read More